LungLife AI Inc
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, I… Read more
LungLife AI Inc (LLAI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: -0.245x
Based on the latest financial reports, LungLife AI Inc (LLAI) has a cash flow conversion efficiency ratio of -0.245x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.94 Million) by net assets (GBX7.93 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
LungLife AI Inc - Cash Flow Conversion Efficiency Trend (2018–2023)
This chart illustrates how LungLife AI Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
LungLife AI Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LungLife AI Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bull Trading And Investment Ltd
TA:BULL
|
N/A |
|
LifeSafe Holdings PLC
LSE:LIFS
|
-0.102x |
|
Cue Health Inc.
NASDAQ:HLTHQ
|
-0.144x |
|
G2M Cap Corp.
V:GTM-P
|
-0.045x |
|
EMBRY HOLDINGS
BE:E3S
|
N/A |
|
MRC Allied Inc
PSE:MRC
|
-0.007x |
|
Marwyn Value Investors Limited
LSE:MVI
|
0.020x |
|
Synthesis Energy Systems Inc
PINK:SYNE
|
0.036x |
Annual Cash Flow Conversion Efficiency for LungLife AI Inc (2018–2023)
The table below shows the annual cash flow conversion efficiency of LungLife AI Inc from 2018 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | GBX7.91 Million | GBX-5.02 Million | -0.634x | -42.62% |
| 2022-12-31 | GBX13.14 Million | GBX-5.84 Million | -0.445x | -18.78% |
| 2021-12-31 | GBX20.13 Million | GBX-7.54 Million | -0.375x | -154.46% |
| 2020-12-31 | GBX19.53 Million | GBX-2.87 Million | -0.147x | -130.12% |
| 2019-12-31 | GBX-6.80 Million | GBX-3.32 Million | 0.489x | -29.30% |
| 2018-12-31 | GBX-3.10 Million | GBX-2.14 Million | 0.691x | -- |